by Clinical Neuropsychologist Online | Monday, October 21, 2024 | Dementia
Abstract INTRODUCTION Cerebrospinal fluid (CSF) α-synuclein (α-syn) seed amplification assay (SAA) is a sensitive and specific tool for detecting Lewy body co-pathology in Alzheimer’s disease. METHODS A total of 1637 cross-sectional and 407 longitudinal CSF...
by Clinical Neuropsychologist Online | Monday, October 21, 2024 | Dementia
Abstract INTRODUCTION This study assessed the association of plasma biomarkers of endothelial dysfunction with cognitive performance and decline. METHODS Data from 9414 individuals from eight Dutch cohorts were included (Ø age-range: 57–93 years). Plasma biomarkers...
by Clinical Neuropsychologist Online | Monday, October 21, 2024 | Dementia
Abstract INTRODUCTION The genetic basis of Alzheimer’s disease (AD) in Koreans is poorly understood. METHODS We performed an AD genome-wide association study using whole-genome sequence data from 3540 Koreans (1583 AD cases, 1957 controls) and single-nucleotide...
by Clinical Neuropsychologist Online | Monday, October 21, 2024 | Neuroscience
Psychology & Neuroscience, Vol 17(4), Dec 2024, 253-281; doi:10.1037/pne0000349Objective: This article aimed to review the unity and diversity model of executive functions, examining its historical evolution, exploring general versus specific executive functions,...
by Clinical Neuropsychologist Online | Friday, October 18, 2024 | Paediatric Neuropsychology
Previous research found the Conners Continuous Performance Test (3rd ed; CCPT3) to predict concussion outcomes, but delivery was on a desktop device which can undermine broad use. We examine whether a shortened, mobile CCPT3 predicts concussion symptom endorsement and...
